Trial intelligence / Profile preview

Phase II study of SMP-862 (metformin) monotherapy in type 2 diabetes

jRCT2080220088Phase 2

Sponsor
Sumitomo Pharma
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Sumitomo Pharma.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT2080220088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call